Funds holding VYNE THERAPEUTICS INC
ISIN US92941V3087 · United States
- Fund holders
- 6
- Of which ETFs
- 0 6 other funds
- Value held
- 298.2K $
| Fund | Shares | Value | Weight in fund | |
|---|---|---|---|---|
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 264,557 | 158.1K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 170,622 | 102.4K $ | 0.00 % | as of Feb 28, 2026 ↗ |
| Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 34,730 | 20.9K $ | as of Feb 28, 2026 ↗ | |
| Fidelity Total Market Index Fund Fidelity Concord Street Trust | 21,393 | 12.8K $ | as of Feb 28, 2026 ↗ | |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 3,700 | 2.2K $ | 0.00 % | as of Mar 31, 2026 ↗ |
| Fidelity Nasdaq Composite Index Fund Fidelity Concord Street Trust | 2,907 | 1.7K $ | as of Feb 28, 2026 ↗ |
The funds most exposed to it
The weight is the share of a fund's net assets. The holders table ranks funds by number of shares. This one ranks them by the weight of the company in each fund.
| Fund | Weight in fund | |
|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 0.00 % | as of Feb 28, 2026 ↗ |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 0.00 % | as of Mar 31, 2026 ↗ |
| Blackstone Alternative Multi-Strategy Fund Blackstone Alternative Investment Funds | 0.00 % | as of Mar 31, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q2 | 6 | 0 | 497,909 | +101.0 % |
| 2026Q1 | 6 | -1 | 247,770 | -23.0 % |
| 2025Q4 | 7 | -1 | 321,739 | -57.4 % |
| 2025Q3 | 8 | -2 | 754,948 | +12.1 % |
| 2025Q2 | 10 | +1 | 673,692 | +2.0 % |
| 2025Q1 | 9 | 0 | 660,731 | -23.7 % |
| 2024Q4 | 9 | +2 | 866,438 | +0.3 % |
| 2024Q3 | 7 | +1 | 863,953 | +39.7 % |
| 2024Q2 | 6 | -2 | 618,262 | -18.0 % |
| 2024Q1 | 8 | -1 | 754,131 | +874.6 % |
| 2023Q4 | 9 | 77,376 |
Institutional managers
39 managers declare this company to the SEC (Form 13F). The table shows the 25 largest.
| Manager | Shares | Value | |
|---|---|---|---|
| Nantahala Capital Management, LLC | 2,000,000 | 1.2M $ | as of Mar 31, 2026 |
| Lynx1 Capital Management LP | 1,628,700 | 973.1K $ | as of Mar 31, 2026 |
| Shay Capital LLC | 1,610,242 | 962.1K $ | as of Mar 31, 2026 |
| Anson Funds Management LP | 1,243,106 | 742.8K $ | as of Mar 31, 2026 |
| ADAR1 Capital Management, LLC | 1,063,899 | 635.7K $ | as of Mar 31, 2026 |
| T3 Companies, LLC | 945,000 | 564.6K $ | as of Mar 31, 2026 |
| BRAIDWELL LP | 916,077 | 547.4K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 514,443 | 307.4K $ | as of Mar 31, 2026 |
| KVP Capital Advisors, LP | 500,551 | 299.1K $ | as of Mar 31, 2026 |
| TWO SIGMA INVESTMENTS, LP | 426,412 | 254.8K $ | as of Mar 31, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | 381,797 | 228 $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 322,711 | 192.8K $ | as of Mar 31, 2026 |
| Ikarian Capital, LLC | 264,912 | 158.3K $ | as of Mar 31, 2026 |
| UBS Group AG | 179,784 | 107.5K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 158,396 | 94.6K $ | as of Mar 31, 2026 |
| Rangeley Capital, LLC | 118,064 | 70.5K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 95,645 | 57.1K $ | as of Mar 31, 2026 |
| BOOTHBAY FUND MANAGEMENT, LLC | 81,371 | 48.6K $ | as of Mar 31, 2026 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 57,784 | 34.5K $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 44,405 | 26.5K $ | as of Mar 31, 2026 |
| FNY Investment Advisers, LLC | 35,000 | 20 $ | as of Mar 31, 2026 |
| HRT FINANCIAL LP | 27,569 | 16 $ | as of Mar 31, 2026 |
| NORTHERN TRUST CORP | 23,110 | 13.8K $ | as of Mar 31, 2026 |
| COMMONWEALTH EQUITY SERVICES, LLC | 18,298 | 10.9K $ | as of Mar 31, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | 17,300 | 10.3K $ | as of Mar 31, 2026 |
Declared shareholders of VYNE THERAPEUTICS INC
There are 2 beneficial ownership filings. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Nantahala Capital Management, LLC and 2 others | 6.00 % | 2,000,000 | as of Mar 31, 2026 · SCHEDULE 13G |
| Zhang Xiaofan | 5.60 % | 1,873,388 | as of Jun 8, 2026 · SCHEDULE 13G |
Cite this page
Titelia. "Funds holding VYNE THERAPEUTICS INC". https://titelia.com/en/stocks/vyne-therapeutics-inc-US92941V3087